NASDAQ:EYES - Second Sight Medical Products Stock Price, Forecast & News

Second Sight Medical Products trades on the NASDAQ under the ticker symbol "EYES."

Second Sight Medical Products Inc (NASDAQ:EYES) released its quarterly earnings results on Thursday, November, 14th. The medical device company reported ($0.06) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.06). The medical device company earned $0.47 million during the quarter, compared to the consensus estimate of $0.94 million. Second Sight Medical Products had a negative net margin of 743.86% and a negative return on equity of 201.34%. View Second Sight Medical Products' Earnings History.

Second Sight Medical Products is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Second Sight Medical Products.

1 brokerages have issued 12 month price targets for Second Sight Medical Products' shares. Their forecasts range from $2.00 to $2.00. On average, they expect Second Sight Medical Products' share price to reach $2.00 in the next twelve months. This suggests that the stock has a possible downside of 52.6%. View Analyst Price Targets for Second Sight Medical Products.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Second Sight Medical Products in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Second Sight Medical Products.

News articles about EYES stock have trended somewhat negative on Monday, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Second Sight Medical Products earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave media coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Second Sight Medical Products.

Some companies that are related to Second Sight Medical Products include Rockwell Medical (RMTI), Soleno Therapeutics (SLNO), Fonar (FONR), BioSig Technologies (BSGM), Edap Tms (EDAP), electroCore (ECOR), IRIDEX (IRIX), Fc Global Realty (FCRE), Helius Medical Technologies (HSDT), Precision Optics (PEYE), ENDRA Life Sciences (NDRA), Digirad (DRAD), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU) and Nexeon Medsystems (NXNN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Second Sight Medical Products investors own include Zynerba Pharmaceuticals (ZYNE), Adaptimmune Therapeutics (ADAP), Cara Therapeutics (CARA), Opko Health (OPK), Shopify (SHOP), Corbus Pharmaceuticals (CRBP), VBI Vaccines (VBIV), TransEnterix (TRXC), Plug Power (PLUG) and Canopy Growth (CGC).

(EYES) raised $32 million in an IPO on Wednesday, November 19th 2014. The company issued 3,500,000 shares at a price of $9.00 per share. MDB Capital Group, LLC served as the underwriter for the IPO.

Shares of EYES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of EYES stock can currently be purchased for approximately $4.22.

Second Sight Medical Products has a market capitalization of $65.71 million and generates $6.90 million in revenue each year. The medical device company earns $-35,090,000.00 in net income (profit) each year or ($4.16) on an earnings per share basis. Second Sight Medical Products employs 123 workers across the globe.View Additional Information About Second Sight Medical Products.

The official website for Second Sight Medical Products is http://www.secondsight.com/.

Second Sight Medical Products' mailing address is 12744 SAN FERNANDO ROAD SUITE 400, SYLMAR CA, 91342. The medical device company can be reached via phone at 818-833-5000 or via email at [email protected]